Cargando…

Updates in the Management of Renal Cell Carcinoma

At JADPRO Live Virtual 2021, advanced practitioner experts reviewed clinical updates in the treatment of renal cell carcinoma, key patient counseling and monitoring considerations, and best practices to manage adverse events associated with therapies for renal cell carcinoma.

Detalles Bibliográficos
Autores principales:	Hanna, Kirollos S., Lim, Zita D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press LLC 2022
Materias:	Meeting Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126346/ https://www.ncbi.nlm.nih.gov/pubmed/35663157 http://dx.doi.org/10.6004/jadpro.2022.13.3.27

Ejemplares similares

2020–2021 Drug Updates in Hematologic Malignancies
por: Hanna, Kirollos
Publicado: (2022)

2019–2020 Drug Updates in Solid Tumors
por: Hanna, Kirollos S.
Publicado: (2021)

2021–2022 Drug Updates in Solid Tumors
por: Hanna, Kirollos
Publicado: (2023)

Medullary carcinoma of the thyroid: an update
por: Alevizaki, Maria
Publicado: (2013)

Updates in Cholangiocarcinoma
por: O’Hagan, Kristen
Publicado: (2022)

Updates in the Diffuse Large B-Cell Lymphoma Treatment Landscape
por: Ames, Ashley, et al.
Publicado: (2022)

2019–2020 Drug Updates in Hematologic Malignancies
por: Finnes, Heidi D.
Publicado: (2021)

Advances in the Management of Patients With Urothelial Carcinomas of the Bladder
por: Shah, Amishi, et al.
Publicado: (2018)

Sarcoma: Disease Overview and Treatment Updates
por: Joseph, Cissimol, et al.
Publicado: (2021)

The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody‐mediated rejection
por: Loupy, Alexandre, et al.
Publicado: (2020)

2020–2021 Drug Updates in Solid Tumors
por: Cambareri, Christine
Publicado: (2022)

Risk factors for chronic kidney disease: an update
por: Kazancioğlu, Rumeyza
Publicado: (2013)

2018–2019 Drug Updates in Solid Tumors
por: Barbour, Sally
Publicado: (2020)

2018–2019 Drug Updates in Hematologic Malignancies
por: Held, Lauren
Publicado: (2020)

2021–2022 Drug Updates in Hematologic Malignancies
por: Tobin, Jenni
Publicado: (2023)

2020–2021 Drug Updates: Investigational Therapeutics in the Pipeline
por: Moore, Donald C.
Publicado: (2022)

Updating the Targeted Therapy Paradigm for Patients With Metastatic NSCLC
por: Florez (DUMA), Narjust, et al.
Publicado: (2023)

2021–2022 Drug Updates: Investigational Therapeutics in the Pipeline
por: Moore, Donald C.
Publicado: (2023)

Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda
por: Chaccour, Carlos J, et al.
Publicado: (2015)

Case study of pancreas-preserving enucleation in the treatment of isolated pancreatic metastases of renal cell carcinoma
por: D'cruz, Toby, et al.
Publicado: (2015)

Pivotal Role of Cardio Thoracic Surgeon in Surgical Management of Metastatic Renal Cell Carcinoma with Supradiaphragmatic Inferior Venecaval Invasion with Long-Term Survival
por: Chandra, Bipin, et al.
Publicado: (2015)

Therapeutic Updates for Richter Syndrome: Highlights From SOHO 2021
Publicado: (2022)

Updates on Clinical Trials for Myelofibrosis: Highlights From SOHO 2021
Publicado: (2022)

Human immunodeficiency virus and liver disease: A comprehensive update
por: Sherman, Kenneth E., et al.
Publicado: (2017)

Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015
por: Galon, J., et al.
Publicado: (2016)

XII AIST 2018 Conference: “The thousand faces of cough: clinical and therapeutic updates”
por: Zanasi, Alessandro, et al.
Publicado: (2018)

New Drug Updates in Hematologic Malignancies: CAR-T, Targeted Therapeutics, and Other Agents
por: Harvey, R. Donald
Publicado: (2018)

Advancements in Therapy for Bladder Cancer: Enfortumab Vedotin
por: Hanna, Kirollos S.
Publicado: (2020)

Optimal management of renal cell carcinoma in octogenarians: Retrospective analysis using updated Korean Renal Cell Carcinoma (KORCC) database
por: Kim, Jung Kwon, et al.
Publicado: (2023)

Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities
por: Graves, Angela, et al.
Publicado: (2013)

First meeting “Cystic echinococcosis in Chile, update in alternatives for control and diagnostics in animals and humans”
por: Alvarez Rojas, Cristian A., et al.
Publicado: (2016)

Updates on Therapeutic Advancements in Relapsed or Refractory Multiple Myeloma: Highlights From SOHO 2020
Publicado: (2021)

Targets of new immunosuppressants in renal transplantation
por: Cruzado, Josep M, et al.
Publicado: (2011)

ISN Forefronts Symposium 2015: The Diverse Function of Macrophages in Renal Disease
por: Duthie, Fiona, et al.
Publicado: (2016)

United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease
por: Collins, Allan J, et al.
Publicado: (2015)

New Drug Updates in Solid Tumors: PARP Inhibitors in Ovarian Cancer, Immunotherapeutics, and Other Agents
por: Li, Edward
Publicado: (2018)

VH update
por: Arnold, Hannah
Publicado: (2022)

Technology update
por: Young, KC
Publicado: (2002)

Guidelines update
por: Demirkiran, Oktay
Publicado: (2015)

Update on the treatment of metastatic renal cell carcinoma
por: Medina López, Rafael Antonio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4q74q0gi1hq21fsqcb50629ef0